Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial-MedSci.cn

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Kullmann, S; Hummel, J; Wagner, R; Dannecker, C; Vosseler, A; Fritsche, L; Veit, R; Kantartzis, K; Machann, J; Birkenfeld, AL; Stefan, N; Haring, HU; Peter, A; Preissl, H; Fritsche, A; Heni, M

Heni, M (通讯作者)，Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Tubingen, Germany.;Heni, M (通讯作者)，German Ctr Diabet Res, Neuherberg, Germany.;Heni, M (通讯作者)，Eberhard Karls Univ Tubingen, Dept Internal Med, Div Diabetol Endocrinol & Nephrol, Tubingen, Germany.;Heni, M (通讯作者)，Eberhard Karls Univ Tubingen, Inst Clin Chem & Pathobiochem, Dept Diagnost Lab Med, Tubingen, Germany.

Abstract

OBJECTIVE Insulin action in the human brain reduces food intake, improves whole-body insulin sensitivity, and modulates body fat mass and its distribu......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

科室

工具

服务